APA (7th ed.) Citation

R, T., T, N., Y, K., T, I., & T, B. (2025). Switching From Aflibercept 2 mg to 8 mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration. Cureus, 17(10), e93645. https://doi.org/10.7759/cureus.93645

Chicago Style (17th ed.) Citation

R, Tamai, Nizawa T, Kawamata Y, Iwase T, and Baba T. "Switching From Aflibercept 2 Mg to 8 Mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration." Cureus 17, no. 10 (2025): e93645. https://doi.org/10.7759/cureus.93645.

MLA (9th ed.) Citation

R, Tamai, et al. "Switching From Aflibercept 2 Mg to 8 Mg in Vitrectomized Eyes With Neovascular Age-Related Macular Degeneration." Cureus, vol. 17, no. 10, 2025, p. e93645, https://doi.org/10.7759/cureus.93645.